JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M300760200 on May 16, 2003

J. Biol. Chem., Vol. 278, Issue 30, 27688-27694, July 25, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/30/27688    most recent
M300760200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, Y.
Right arrow Articles by Tall, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Y.
Right arrow Articles by Tall, A. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid {beta} Peptide Secretion*

Yu Sun {ddagger}, Jun Yao §, Tae-Wan Kim § ¶ and Alan R. Tall {ddagger} ||

From the {ddagger}Division of Molecular Medicine, Department of Medicine and the §Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032

A hallmark of Alzheimer's disease is the deposition of plaques of amyloid {beta} peptide (A{beta}) in the brain. A{beta} is thought to be formed from the amyloid precursor protein (APP) in cholesterol-enriched membrane rafts, and cellular cholesterol depletion decreases A{beta} formation. The liver X receptors (LXR) play a key role in regulating genes that control cellular cholesterol efflux and membrane composition and are widely expressed in cells of the central nervous system. We show that treatment of APP-expressing cells with LXR activators reduces the formation of A{beta}. LXR activation resulted in increased levels of the ATP-binding cassette transporter A1 (ABCA1) and stearoyl CoA desaturase, and expression of these genes individually decreased formation of A{beta}. Expression of ABCA1 led to both decreased {beta}-cleavage product of APPSw (i.e. C99 peptide) and reduced {gamma}-secretase-cleavage of C99 peptide. Remarkably, these effects of ABCA1 on APP processing were independent of cellular lipid efflux. LXR and ABCA1-induced changes in membrane lipid organization had favorable effects on processing of APP, suggesting a new approach to the treatment of Alzheimer's disease.


Received for publication, January 23, 2003 , and in revised form, May 15, 2003.

* This work is supported by National Institutes of Health Grants HL 22682 and 54591 (to A. R. T.) and NIA, National Institutes of Health Grant AG18026 (to T.-W. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Ellison Medical Foundation New Scholar in Aging.

|| To whom correspondence should be addressed. Tel.: 212-305-9418; Fax: 212-305-5052; E-mail: art1{at}columbia.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
J. R. Morales, I. Ballesteros, J. M. Deniz, O. Hurtado, J. Vivancos, F. Nombela, I. Lizasoain, A. Castrillo, and M. A. Moro
Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke
Circulation, September 30, 2008; 118(14): 1450 - 1459.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al.
ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo
J. Lipid Res., June 1, 2008; 49(6): 1254 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Zelcer, N. Khanlou, R. Clare, Q. Jiang, E. G. Reed-Geaghan, G. E. Landreth, H. V. Vinters, and P. Tontonoz
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
PNAS, June 19, 2007; 104(25): 10601 - 10606.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. H. Tansley, B. L. Burgess, M. T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J. Y. Chan, A. Wilkinson, J. Evans, K. E. Naus, et al.
The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein
J. Lipid Res., May 1, 2007; 48(5): 1022 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner
Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation
J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al.
Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES
J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Koldamova, M. Staufenbiel, and I. Lefterov
Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice
J. Biol. Chem., December 30, 2005; 280(52): 43224 - 43235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Wahrle, H. Jiang, M. Parsadanian, R. E. Hartman, K. R. Bales, S. M. Paul, and D. M. Holtzman
Deletion of Abca1 Increases Abeta Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease
J. Biol. Chem., December 30, 2005; 280(52): 43236 - 43242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Hirsch-Reinshagen, L. F. Maia, B. L. Burgess, J.-F. Blain, K. E. Naus, S. A. McIsaac, P. F. Parkinson, J. Y. Chan, G. H. Tansley, M. R. Hayden, et al.
The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease
J. Biol. Chem., December 30, 2005; 280(52): 43243 - 43256.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. F. Oram and J. W. Heinecke
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Physiol Rev, October 1, 2005; 85(4): 1343 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Rigamonti, L. Helin, S. Lestavel, A.L. Mutka, M. Lepore, C. Fontaine, M.A. Bouhlel, S. Bultel, J.C. Fruchart, E. Ikonen, et al.
Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages
Circ. Res., September 30, 2005; 97(7): 682 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Heverin, S. Meaney, D. Lutjohann, U. Diczfalusy, J. Wahren, and I. Bjorkhem
Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain
J. Lipid Res., May 1, 2005; 46(5): 1047 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Koldamova, I. M. Lefterov, M. Staufenbiel, D. Wolfe, S. Huang, J. C. Glorioso, M. Walter, M. G. Roth, and J. S. Lazo
The Liver X Receptor Ligand T0901317 Decreases Amyloid {beta} Production in Vitro and in a Mouse Model of Alzheimer's Disease
J. Biol. Chem., February 11, 2005; 280(6): 4079 - 4088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Wahrle, H. Jiang, M. Parsadanian, J. Legleiter, X. Han, J. D. Fryer, T. Kowalewski, and D. M. Holtzman
ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE
J. Biol. Chem., September 24, 2004; 279(39): 40987 - 40993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Hirsch-Reinshagen, S. Zhou, B. L. Burgess, L. Bernier, S. A. McIsaac, J. Y. Chan, G. H. Tansley, J. S. Cohn, M. R. Hayden, and C. L. Wellington
Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain
J. Biol. Chem., September 24, 2004; 279(39): 41197 - 41207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Brown III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, et al.
Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease
J. Biol. Chem., August 13, 2004; 279(33): 34674 - 34681.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. Wolozin
Apolipoprotein E Receptor LR11: Intersections Between Neurodegeneration and Cholesterol Metabolism
Arch Neurol, August 1, 2004; 61(8): 1178 - 1180.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Wang, D. Lan, W. Chen, F. Matsuura, and A. R. Tall
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
PNAS, June 29, 2004; 101(26): 9774 - 9779.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.